Halozyme Therapeutics Inc (HALO)

[rod5247]

"Hizentra®, the first and only ready-to-use 20% solution for subcutaneous infusion (SCIg), is a weekly or bi-weekly therapy that can be safely self-administered. Hizentra® provides effective protection against infection by maintaining a steady and normal level of immunoglobulin in the body. Made with L-proline, Hizentra is ready to use; it requires no refrigeration throughout its 30-month shelf-life, offering patients and physicians convenience, portability and flexible dosing."

Since 2010

Surely direct competition to someone.

What happens if Shire adds Hylenex now that theirs is approved?